TELA Bio (TELA) Assets Average (2018 - 2026)

TELA Bio has reported Assets Average for 9 years, with the latest figure at $64.8 million in Q2 2026.

• On a quarterly basis, Assets Average fell 10.47% year-over-year to $64.8 million in Q2 2026; TTM through Jun 2026 was $64.8 million, a 10.47% decrease from a year earlier, with the FY2025 full-year figure at $84.0 million, up 2.05% from the prior year.
• Assets Average was $64.8 million for Q2 2026 at TELA Bio, down from $75.7 million in the prior quarter.
• The five-year high for Assets Average was $90.9 million in Q3 2023, with the low at $53.3 million in Q2 2022.
• Average Assets Average over 5 years is $70.2 million, with a median of $70.6 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Assets Average surged 43.57% in 2023, then sank 37.69% in 2024.
• Over 5 years, Assets Average stood at $73.7 million in 2022, then advanced by 12.17% to $82.7 million in 2023, then slipped by 15.59% to $69.8 million in 2024, then climbed by 2.45% to $71.5 million in 2025, then decreased by 9.35% to $64.8 million in 2026.
• The last three Assets Average figures came in at $64.8 million (Q2 2026), $75.7 million (Q1 2026), and $71.5 million (Q4 2025), per Business Quant data.